N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products
Open Access
- 15 August 2022
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 40 (9) , 111300
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P30 CA091842)
- National Institute of General Medical Sciences (R01GM141474)
- National Center for Advancing Translational Sciences (UL1 TR002345)
- Institute of Clinical and Translational Sciences
- National Institutes of Health
This publication has 61 references indexed in Scilit:
- Rationalization and prediction of selective decoding of pseudouridine-modified nonsense and sense codonsRNA, 2012
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNANucleic Acids Research, 2011
- Converting nonsense codons into sense codons by targeted pseudouridylationNature, 2011
- Hyperaccurate and Error-Prone Ribosomes Exploit Distinct Mechanisms during tRNA SelectionMolecular Cell, 2010
- Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activationNucleic Acids Research, 2010
- Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome ProfilingScience, 2009
- Quality control by the ribosome following peptide bond formationNature, 2008
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008
- Preparation and evaluation of acylated tRNAsMethods, 2008
- Pathogen Recognition and Innate ImmunityCell, 2006